Expanding limited treatment options
At Janssen Oncology, we focus our efforts on discovering first of a kind, innovative medicines for cancers where there are limited treatment options.
In Europe, cancer causes one in five deaths and is the second leading cause of premature death.
We focus on discovering first-in-class, innovative medicines for cancers where there are limited treatment options.
We want patients receiving a diagnosis for cancer who may feel overwhelmed and uncertain of what lies ahead, to know that in laboratories, doctors’ offices and conference halls across Europe, Janssen people are working relentlessly on their behalf to deliver the treatments that they need to be able to get back to ‘normal life’.
Find out more about the cancers we are trying to find treatments for: http://janssen.com/emea/oncology-infographics
Our efforts will continue as long as there are still people who need new treatment options. Because patients are at the heart of everything we do at Janssen. For them, we dedicate ourselves to developing transformational treatment solutions that improve lives and enable those affected by cancer to enjoy more of life’s meaningful moments. Hear more from one of these patients:
 Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. European Journal of Cancer. 2013;49:1374–1403.
Find out more about working at Janssen Oncology.
Revolutionise your career in oncology and apply for a job at Janssen here.